National Primary Health Care Development Agency (NPHCDA) has disclosed that Nigeria will receive 41,282,770 doses of Oxford/Astrazeneca, Pfizer-Bio-N Tech and Johnson & Johnson (Jassen) COVID-19 vaccine from the COVAX facility between August and September 2021. Executive Director of NPHCDA, Dr Faisal Shuaib stated this at a media briefing on the progress of the COVID-19 vaccine exercise on Tuesday in Abuja. He added “3,930,910 doses of Pfizer-Bio-N Tech COVID-19 vaccine in August from the COVAX facility donated by the United States Government and 3,577,860 doses of Pfizer-Bio-N Tech COVID-19 vaccine in Q3 from the COVAX facility. Shuaib further disclosed that additional 29,850,000 doses of the Johnson & Johnson (Jassen) COVID-19 vaccine by the end of September will arrive in batches from the African Union Commission. “With the leadership of Eminent Nigerians, the Federal Ministry of Health and its agencies are continuing the process of supporting our local partner, Biovaccines Nigeria limited towards establishing local vaccine production.”“With the detection of the Delta Variant of COVID-19 in Nigeria, it is important that Nigerians continue to observe non-pharmaceutical or public health measures such as wearing of facemask, social distancing and hand hygiene in order to curb the transmission of the disease, while we await additional doses of the COVID-19 vaccines.”YOU SHOULD NOT MISS THESE HEADLINES FROM NIGERIAN TRIBUNEBuhari Urges MTN For Quality Service, Downward Price Review In Cost Of Data, Other ServicesPresident Muhammadu Buhari Friday at State House Abuja urged the MTN Group to make the available top-of-the-range service to its Nigerian subscribers… Nigeria to receive over 40 million doses in September ; Nigeria to receive over 40 million doses in September ; Nigeria to receive over 40 million doses in September ; Nigeria to receive over 40 million doses in September.

Source: Nigerian Tribune July 13, 2021 16:07 UTC